Danila Comandini

630 total citations
31 papers, 446 citations indexed

About

Danila Comandini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Danila Comandini has authored 31 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Gastroenterology. Recurrent topics in Danila Comandini's work include Gastrointestinal Tumor Research and Treatment (10 papers), Sarcoma Diagnosis and Treatment (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). Danila Comandini is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (10 papers), Sarcoma Diagnosis and Treatment (8 papers) and Colorectal Cancer Treatments and Studies (5 papers). Danila Comandini collaborates with scholars based in Italy, United States and Slovakia. Danila Comandini's co-authors include Lazzaro Repetto, Serafina Mammoliti, F Badellino, Marco Gipponi, Pierluigi Percivale, Paola Queirolo, Sergio Bertoglio, Ferdinando Cafiero, Mario Roberto Sertoli and Salvatore Siena and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Danila Comandini

30 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danila Comandini Italy 11 269 191 88 62 55 31 446
Robert Díaz Beveridge Spain 11 172 0.6× 139 0.7× 63 0.7× 28 0.5× 18 0.3× 43 317
Gina Villani United States 10 214 0.8× 133 0.7× 49 0.6× 22 0.4× 13 0.2× 24 456
Kozo Miyatani Japan 15 328 1.2× 282 1.5× 211 2.4× 21 0.3× 44 0.8× 80 700
A.C. Braud France 13 483 1.8× 192 1.0× 198 2.3× 10 0.2× 67 1.2× 23 739
Seiichiro Mitani Japan 11 258 1.0× 195 1.0× 87 1.0× 7 0.1× 37 0.7× 69 513
Dirk Elling Germany 16 303 1.1× 115 0.6× 194 2.2× 32 0.5× 14 0.3× 51 656
Hideo Baba Japan 14 342 1.3× 131 0.7× 262 3.0× 22 0.4× 11 0.2× 26 573
Lieke H. J. Simkens Netherlands 12 376 1.4× 135 0.7× 188 2.1× 55 0.9× 8 0.1× 24 655
Yukiya Narita Japan 14 374 1.4× 363 1.9× 171 1.9× 8 0.1× 90 1.6× 98 732
Jason W. Denbo United States 17 581 2.2× 390 2.0× 412 4.7× 53 0.9× 23 0.4× 61 823

Countries citing papers authored by Danila Comandini

Since Specialization
Citations

This map shows the geographic impact of Danila Comandini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danila Comandini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danila Comandini more than expected).

Fields of papers citing papers by Danila Comandini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danila Comandini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danila Comandini. The network helps show where Danila Comandini may publish in the future.

Co-authorship network of co-authors of Danila Comandini

This figure shows the co-authorship network connecting the top 25 collaborators of Danila Comandini. A scholar is included among the top collaborators of Danila Comandini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danila Comandini. Danila Comandini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pastorino, Alessandro, Marta Ponzano, Massimiliano Grassi, et al.. (2023). Reliability of patient-reported toxicities during adjuvant chemotherapy. European Journal of Cancer. 182. 115–121. 1 indexed citations
3.
Campora, Michela, Michele Paudice, Alessandro Gambella, et al.. (2022). Counting mitoses in gastrointestinal stromal tumours (GISTs): variable practices in the real-world setting and their clinical implications. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(3). 589–594. 3 indexed citations
5.
Astolfi, Annalisa, Valentina Indio, Margherita Nannini, et al.. (2020). Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST. Frontiers in Oncology. 10. 504–504. 17 indexed citations
6.
Comandini, Danila, et al.. (2020). Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis. Neoplasma. 67(6). 1416–1423. 1 indexed citations
7.
Comandini, Danila, et al.. (2017). Synchronous GISTs associated with multiple sporadic tumors: a case report. Drugs in Context. 6. 1–4. 5 indexed citations
8.
Origone, Paola, Sara Gargiulo, Luca Mastracci, et al.. (2013). Molecular characterization of an Italian series of sporadic GISTs. Gastric Cancer. 16(4). 596–601. 17 indexed citations
9.
Mammoliti, Serafina, Francesco Caprioni, Danila Comandini, et al.. (2010). Two doses of NGR-hTNF in combination with capecitabine plus oxaliplatin in colorectal cancer patients failing standard therapies. Annals of Oncology. 22(4). 973–978. 16 indexed citations
10.
Pessino, A., Salvatore Artale, Stefania Sciallero, et al.. (2007). First-line single-agent cetuximab in patients with advanced colorectal cancer. Annals of Oncology. 19(4). 711–716. 38 indexed citations
11.
Siena, Salvatore, Marc Peeters, Eric Van Cutsem, et al.. (2007). Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab. British Journal of Cancer. 97(11). 1469–1474. 65 indexed citations
12.
Repetto, Lazzaro, et al.. (2004). Weekly Paclitaxel in Elderly Patients with Advanced Breast Cancer. Drugs in R&D. 5(1). 11–15. 5 indexed citations
13.
Sobrero, Alberto F., Francesco Caprioni, Giuseppe Fornarini, et al.. (2004). Pemetrexed in gastric cancer.. PubMed. 18(13 Suppl 8). 51–5. 3 indexed citations
14.
Repetto, Lazzaro, Danila Comandini, & Serafina Mammoliti. (2001). Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients. Critical Reviews in Oncology/Hematology. 37(2). 147–152. 70 indexed citations
15.
Venturino, Antonella, Danila Comandini, Cristina Granetto, et al.. (2000). Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability. Breast Cancer Research and Treatment. 62(3). 217–222. 8 indexed citations
17.
Repetto, Lazzaro & Danila Comandini. (2000). Cancer in the elderly: assessing patients for fitness. Critical Reviews in Oncology/Hematology. 35(3). 155–160. 27 indexed citations
18.
Comandini, Danila, et al.. (1999). [Malignant phyllodes tumor with liposarcomatous differentiation. Description of a clinical case].. PubMed. 54(5). 355–8. 5 indexed citations
19.
Scala, Marcello, et al.. (1998). [Precancerous lesions of the oral cavity: review of the literature and an analysis of cases].. PubMed. 18(1). 7–10.
20.
Margarino, G, Marco Scala, Danila Comandini, et al.. (1996). Combined craniofacial approach to facial tumours involving the anterior skull base. European Journal of Surgical Oncology. 22(4). 361–365. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026